Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
One of the most pressing problems is the risk that US drug prices will rise for the NHS.
I am sure that I am not alone in hoping that the BMJ will commission authoritative pieces on the true nature and scale of the risk.
May I humbly offer the suggestion that the BMJ and The Pharmaceutical Journal make common cause in this task. This may be the moment to start to consider initiating the process of minimising harms that will arise from a rise in prices. We can start immediately on reducing all US drug usage both for new and repeat prescriptions. There will be some pharmaceutical products that have to come from the US and we should know which they are.
Are the BMJ and PJ willing to refuse to carry adverts from US companies? Might comparable EU publications be willing to show solidarity in this matter?